| Release |
Date |
Change Notifications |
| Title |
CN No. |
| 74 |
26 November 2024 |
Migraine and Topiramate |
51 - 2024 |
| Monoclonal Antibody Therapies |
49 - 2024 |
| Haemolytic Anaemia |
48 - 2024 |
| Topical Anti-Androgens |
47 - 2024 |
| COVID-19 Vaccinations |
46 - 2024 |
| 73 |
07 October 2024 |
Links to Immunodeficiency entry in WB-DSG |
43 - 2024 |
| Cerebrovascular Disease and Intracranial Haemorrhage |
30 - 2024 |
| Platelet Disorders |
27 - 2024 |
| 72 |
31 July 2024 |
Faints |
26 - 2024 |
| Dental Treatment |
25 - 2024 |
| Upper Age Limit for Returning Donors |
22 - 2024 |
| Cardiovascular Disease |
21 - 2024 |
| Bleeding Disorder |
20 - 2024 |
| Pyrexia and Infection |
19 - 2024 |
| Animal Bite (Non-Human) |
18 - 2024 |
| Osteoarthritis |
17 - 2024 |
| Drugs and Platelet Donation |
16 - 2024 |
| Shunts, Stents and Devices |
15 - 2024 |
| Fertility |
14 - 2024 |
| 71 |
02 May 2024 |
Travel Criteria for Plasmapheresis Donors |
08 - 2024 |
| Immunosuppression |
07 - 2024 |
| 70 |
18 April 2024 |
Transgender and Non-Binary Donors |
09 - 2024 |
| Hepatitis A and Parvovirus B19 |
06 - 2024 |
| 69 |
04 July 2023 |
Chronic Fatigue Syndrome |
29 - 2023 |
| Blood Safety Entry |
28 - 2023 |
| Air Crew and Air Traffic Controllers |
27 - 2023 |
| 68 |
09 May 2023 |
Hepatitis B and Hepatitis of Unknown Cause |
13 - 2023 |
| Tropical Viruses |
12 - 2023 |
| Recurrent Thrombophlebitis |
11 - 2023 |
| Frequency of Donation |
10 - 2023 |
| 67 |
31 January 2023 |
Mpox (Monkeypox) |
04 - 2023 |
| Donor Weight |
03 - 2023 |
| Dental Treatment |
02 - 2023 |
| 66 |
18 October 2022 |
Platelet Count |
59 - 2022 |
| Liver Disease |
58 - 2022 |
| Thrombosis and Thrombophilia |
57 - 2022 |
| Air Crew and Air Traffic Controllers |
13 - 2023 |
| 65 |
30 August 2022 |
Table of Immunisations |
49 - 2022 |
| Hepatitis of Unknown Cause |
48 - 2022 |
| Coronavirus Infection |
46 - 2022 |
| Surgery |
45 - 2022 |
| Sleep Apnoea |
44 - 2022 |
| Addiction and Drug Abuse |
43 - 2022 |
| 64 |
26 April 2022 |
Monkeypox |
40 - 2022 |
| Hepatitis B |
39 - 2022 |
| 64 |
31 May 2022 |
Body Piercing |
28 - 2022 |
| Conn's Syndrome |
27 - 2022 |
| Ehlers Danlos Syndrome |
26 - 2022 |
| Narcolepsy |
25 - 2022 |
| Appendix 4 - Management of post donation illness |
22 - 2022 |
| Tropical Viruses |
21 - 2022 |
| Inflammatory Bowel Disease |
20 - 2022 |
| Indwelling Shunts and Stents |
19 - 2022 |
| 62 |
07 April 2022 |
Coronavirus Infection |
29 - 2022 |
| 61 |
22 February 2022 |
Trying to Conceive |
08 - 2022 |
| Non-Contagious Disease |
07 - 2022 |
| Malignancy |
06 - 2022 |
| Kidney & Bladder Disease |
05 - 2022 |
| Complementary Therapy |
04 - 2022 |
| Alopecia |
03 - 2022 |
| Allergy |
02 - 2022 |
| 60 |
20 January 2022 |
Coronavirus Infection |
01 - 2022 |
| 59 |
21 December 2021 |
Blood Safety Entry |
45 - 2021 |
| 58 |
22 June 2021 |
Plasma Changes |
15 - 2021 |
| 57 |
26 May 2021 |
The FAIR Study |
16 - 2021 |
| 56 |
05 May 2021 |
Hypercholesterolaemia |
08 - 2021 |
| Diabetes Mellitus |
07 - 2021 |
| Coronavirus Infection |
06 - 2021 |
| 55 |
21 January 2021 |
Coronavirus Infection |
04 - 2021 |
| Acitretin in Acne, Psoriasis and Skin Disease |
72 - 2020 |
| Body Piercing |
71 - 2020 |
| Drug Index |
70 - 2020 |
| Animal Bites and Rabies |
69 - 2020 |
| South American Trypanosomiasis |
58 - 2020 |
| Viral Haemorrhagic Fever |
57 - 2020 |
| Sodium Valproate |
56 - 2020 |
| Tropical Viruses |
55 - 2020 |
| Latent Tuberculosis |
54 - 2020 |
| Haemochromatosis |
53 - 2020 |
| Cervical Carcinoma in Situ |
52 - 2020 |
| Clopidogrel |
51 - 2020 |
| 54 |
16 December 2020 |
COVID-19 Vaccine |
73 - 2020 |
| 53 |
13 November 2020 |
Clinical Trials |
65 - 2020 |
| Coronavirus Infection |
64 - 2020 |
| 52 |
21 September 2020 |
Transfusion |
48 - 2020 |
| 51 |
08 June 2020 |
Coronavirus Infection |
29 - 2020 |
| 50 |
01 June 2020 |
Northern Ireland - Donor Selection Changes 2020 |
28 - 2020 |
| 49 |
07 May 2020 |
Haemaglobin Estimation |
26 - 2020 |
| 48 |
07 May 2020 |
Coronavirus Infection |
13 - 2020 |
| 47 |
24 February 2020 |
Coronavirus Infection |
09 - 2020 |
| 46 |
17 February 2020 |
Coronavirus Infection |
08 - 2020 |
| 45 |
24 January 2020 |
Coronavirus Infection |
03 - 2020 |
| 44 |
03 September 2019 |
Palpitations & Arrhythmias |
27 - 2019 |
| Familial Psuedohyperkalaemia |
26 - 2019 |
| 43 |
28 May 2019 |
HCV (Northern Ireland) |
11 - 2019 |
| HTLV |
10 - 2019 |
| Cervical Carcinoma in Situ |
09 - 2019 |
| Blood Safety Entry (England, Scotland, Wales) |
08 - 2019 |
| Blood Safety Entry (Northern Ireland) |
07 - 2019 |
| Pre- and Post-Exposure Prophylaxis for HIV Prevention |
04 - 2019 |
| Pregnancy |
03 - 2019 |
| Malignancy |
02 - 2019 |
| Hepatitis C |
01 - 2019 |
| 42 |
17 September 2018 |
Narcolepsy |
21 - 2018 |
| Hepatitis A |
20 - 2018 |
| 41 |
10 May 2018 |
Hepatitis E |
17 - 2018 |
| 40 |
27 November 2017 |
Surgery |
52 - 2017 |
| Endoscopy |
51 - 2017 |
| Bleeding Disorder |
49 - 2017 |
| Syphilis |
47 - 2017 |
| Sex Worker |
45 - 2017 |
| Non-Consented Exposure to Human Body Fluids |
44 - 2017 |
| HTLV |
41 - 2017 |
| Homosexual and Bisexual Individuals |
39 - 2017 |
| HIV |
37 - 2017 |
| Hepatitis C |
35 - 2017 |
| Hepatitis B |
33 - 2017 |
| Complementary Therapy |
31 - 2017 |
| Body Piercing |
29 - 2017 |
| Blood Safety Entry |
26 - 2017 |
| 39 |
26 September 2017 |
Drug Index |
19 - 2017 |
| Thyroid |
18 - 2017 |
| 38 |
01 August 2017 |
Malaria |
15 - 2017 |
| Tissue and Organ Recipients |
14 - 2017 |
| Radiation Therapy |
13 - 2017 |
| Eye Disease |
12 - 2017 |
| Autoimmune Disease and Osteopenia |
11 - 2017 |
| 37 |
21 February 2017 |
Hepatitis A |
04 - 2017 |
| Central Nervous System Disease |
03 - 2017 |
| 36 |
01 November 2016 |
Cardiac Surgery clarification |
37 - 2016 |
| 35 |
01 September 2016 |
Blood Safety Entry & Homosexual and Bisexual Individuals |
36 - 2016 |
| 34 |
23 August 2016 |
Tropical Viruses |
35 - 2016 |
| 33 |
05 July 2016 |
Immunoglobulin |
21 - 2016 |
| High Haemoglobin |
20 - 2016 |
| Disabled Donor |
19 - 2016 |
| Acne |
18 - 2016 |
| 32 |
02 February 2016 |
Viral Haemorrhagic Fever |
15 - 2016 |
| Tropical Viruses |
14 - 2016 |
| 31 |
18 January 2016 |
Viral Haemorrhagic Fever |
11 - 2016 |
| West Nile Virus |
09 - 2016 |
| Tropical Viruses |
08 - 2016 |
| Kidney and Bladder Disease |
06 - 2016 |
| Memorial Tattoos and Body Piercing |
05 - 2016 |
| Appendix 2 - Table of Immunisations |
04 - 2016 |
| Hepatitis E |
03 - 2016 |
| Hepatitis A |
02 - 2016 |
| Glycogen Storage Disease |
01 - 2016 |
| 30 |
06 October 2015 |
Chronic Fatigue Syndrome |
26 - 2015 |
| Alopecia and Autoimmune Disease |
25 - 2016 |
| 29 |
23 June 2015 |
Injectable Tanning Agents |
15 - 2015 |
| The changes made to the Blood Safety Entry have also been applied to the Blood and Tissue Safety Entry (Northern Ireland). Injectable Tanning Agents has been added to index and linked to Blood Safety Entry (England, Scotland and Wales). |
| Complementary Therapy |
12 - 2015 |
| Communication Difficulties |
11 - 2015 |
| Central Nervous System |
10 - 2015 |
| 28 |
17 March 2015 |
Nonsteroidal Anti-Inflammatory Drugs and Drug Index |
05 - 2015 |
| Malignancy |
04 - 2015 |
| Kidney and Bladder Disease |
03 - 2015 |
| Asthma |
02 - 2015 |
| 27 |
17 December 2014 |
Thrombosis |
48 - 2014 |
| Respiratory Disease |
47 - 2014 |
| Mental Health Problems |
46 - 2014 |
| Tuberculosis |
45 - 2014 |
| Hepatitis of Unknown Cause |
44 - 2014 |
| 26 |
20 October 2014 |
Viral Haemorrhagic Fever Risk |
43 - 2014 |
| 25 |
14 October 2014 |
West Nile Virus |
42 - 2014 |
| 24 |
19 August 2014 |
Chikungunya Virus Risk |
41 - 2014 |
| 23 |
08 July 2014 |
Chikungunya Virus Risk |
27 - 2014 |
| 22 |
17 June 2014 |
Chikungunya Virus |
26 - 2014 |
| Vitamins and Other Nutritional Supplements |
24 - 2014 |
| Osteopenia |
23 - 2014 |
| Kidney and Bladder Disease |
22 - 2014 |
| Complementary Therapy |
21 - 2014 |
| Central Nervous System Disease |
20 - 2014 |
| Autoimmune Disease |
19 - 2014 |
| Accept |
18 - 2014 |
| 21 |
13 February 2014 |
Chikungunya Virus |
01 - 2014 |
| 20 |
11 February 2014 |
Surgery |
22 - 2014 |
| South American Trypanosomiasis |
21 - 2014 |
| Skin Disease and Dermatitis (Alitretinoin) |
20 - 2014 |
| Malignancy |
18 - 2014 |
| 19 |
03 September 2013 |
West Nile Virus |
14 - 2013 |
| 18 |
09 July 2013 |
Wounds, Mouth and Skin Ulcers |
07 - 2013 |
| Cardiovascular Disease |
06 - 2013 |
| Chest Pain |
05 - 2013 |
| Chronic Infection |
03 - 2013 |
| Hepatitis B |
02 - 2013 |
| 17 |
04 June 2013 |
West Nile Virus |
01 - 2013 |
| 16 |
05 February 2013 |
Compression Illness |
29 - 2012 |
| Kidney Disease |
28 - 2012 |
| Sickle-Cell Trait |
27 - 2013 |
| 15 |
31 October 2012 |
West Nile Virus |
26 - 2012 |
| West Nile Virus |
25 - 2012 |
| 14 |
31 October 2012 |
Mobilised Granulocytes |
24 - 2012 |
| Cardiovascular Disease |
23 - 2012 |
| Cupping/Wet Cupping |
22 - 2012 |
| West Nile Virus |
21 - 2012 |
| Malaria |
20 - 2012 |
| 13 |
28 August 2012 |
West Nile Virus |
19 - 2012 |
| 12 |
29 June 2012 |
Cardiac Surgery |
13 - 2012 |
| Cardiovascular Disease |
12 - 2012 |
| Skin Disease |
11 - 2012 |
| Dermatitis |
10 - 2012 |
| Pregnancy |
09 - 2012 |
| Psoriasis |
08 - 2012 |
| Toxoplasmosis |
07 - 2012 |
| Acne |
06 - 2012 |
| 11 |
28 March 2012 |
West Nile Virus |
03 - 2012 |
| 10 |
24 January 2012 |
Hepatitis C |
26 - 2012 |
| XMRV |
25 - 2012 |
| Surgery |
24 - 2012 |
| Cardiovascular Disease |
23 - 2012 |
| Donor Weight |
22 - 2012 |
| 09 |
07 November 2011 |
West Nile Virus |
19 - 2011 |
| Homosexual and Bisexual Individuals |
17 - 2011 |
| Blood Safety Entry |
16 - 2011 |
| 08 |
04 October 2011 |
West Nile Virus |
18 - 2011 |
| 07 |
31 August 2011 |
West Nile Virus |
15 - 2011 |
| 06 |
08 August 2011 |
West Nile Virus |
11 - 2011 |
| 05 |
07 June 2011 |
Porphyria |
05 - 2011 |
| Syphilis |
04 - 2011 |
| Immunisation - Live |
03 - 2011 |
| Trying to Conceive |
02 - 2011 |
| Pregnancy |
01 - 2011 |
| 04 |
01 February 2011 |
Donor Weight and Donation Volumes |
13 - 2010 |
| 03 |
01 November 2010 |
Chronic Fatigue Syndrome |
08 - 2010 |
| 02 |
01 September 2010 |
West Nile Virus |
09 - 2010 |
| 01 |
01 June 2010 |
|